Toronto, Ontario–(Newsfile Corp. – June 21, 2024) – Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) (“Safe Supply” or “the Company”) announces today that Frank Salvati has resigned from the Company’s Board of Directors, effective immediately.
The Board is considering the Company’s options with respect to the future composition of the Board and will issue a further news release if and when a replacement is identified.
Bill Panagiotakopoulos, CEO of Safe Supply, commented: “The Company would like to thank Frank for lending his time and expertise to executing Safe Supply’s strategies. We continue to look to review investments in emerging tech and medical testing companies and press forward in addressing current healthcare challenges.”
About Safe Supply Streaming Corp
Safe Supply Streaming Corp. (CSE: SPLY) is a publicly traded company focused on innovative healthcare solutions, including safe supply methodologies, medical testing, and AI-powered technology. The Company is dedicated to improving mental health and addiction treatment through cutting-edge advancements and strategic partnerships.
Investor Relations Contact:
Safe Supply Streaming Corp.
Email: info@safesupply.com
Phone: (123) 456-7890
Bill Panagiotakopoulos
Chief Executive Officer and Director
bill@safesupply.com
Website: www.safesupply.com
Forward-Looking Information and Statements
This press release contains forward-looking statements. All statements, other than statements of historical fact, that address activities, events, or developments that the Company believes, expects, or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/214023
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…